Biomarkers such as prostate-specific antigen (PSA), cancer-antigen 125 (CA-125), and carcinoembryonic antigen (CEA) [8] are commonly sought-after detection targets that allow healthcare specialists to loosely attribute the upregulation of these biomarkers to the presence of cancers in the body. This evidence concerns the gene KLK3 and cancer.